First description of De Novo Inflammatory Bowel Disease (IBD) in two adolescent patients after lung transplant (LTX)

D. Kotzia (Cambridge, United Kingdom), F. Kiparissi (London, United Kingdom), H. Spencer (London, United Kingdom)

Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Session: Interesting clinical problems for the respiratory physician
Session type: E-poster session
Number: 2736
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Kotzia (Cambridge, United Kingdom), F. Kiparissi (London, United Kingdom), H. Spencer (London, United Kingdom). First description of De Novo Inflammatory Bowel Disease (IBD) in two adolescent patients after lung transplant (LTX). 2736

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Impact of Inflammatory bowel disease in bronchiectasis (IBD-BR) data from the EMBARC registry
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018

King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD)
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020

Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch
Source: International Congress 2014 – ILDs 2
Year: 2014

Benefit of steroid-free treatment compared to standard therapy (ST) in pulmonary sarcoidosis
Source: International Congress 2014 – ILDs 5
Year: 2014

Venous thromboembolic disease (VTD) associated with inflammatory bowel disease (IBD): RIETE´s experience
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

TB status in a dynamic cohort of patients with Inflammatory Bowel Disease receiving immunosuppression treatment, with up to 8 years of follow-up.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I
Year: 2019

Associations of gut microbiota and Chronic Obstructive Pulmonary Disease Assessment Test (CAT) score in chemotherapy treated lung cancer patients with COPD
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019

Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014

Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021

Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015

Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020

Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Clinical picture analysis of idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) concomitance in the population of patients hospitalized in Ist Clinic of Lung Diseases Institute for Tuberculosis and Lung Diseases in Warsaw, Poland in the years 1994-2009
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients?
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014

Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used
Source: International Congress 2017 – Rare diseases
Year: 2017

Unclassifiable Interstitial Lung Disease (ILD). Why?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021

Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019

Sporadic and TSC-related lymphangioleiomyomatosis (LAM): The experience of Ospedale San Paolo of Milan (preliminary data)
Source: International Congress 2014 – ILDs 3
Year: 2014

Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark
Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes
Year: 2021